Previous 10 | Next 10 |
home / stock / medif / medif news
For the past eight weeks, we've witnessed record-breaking volatility in the stock market as a result of the coronavirus disease 2019 (COVID-19). The mitigation measures currently put in place to curb the transmission of COVID-19 have shut down most nonessential business activity and wound up pus...
Profitability is extremely hard to come by amongst marijuana stocks . With so many companies in the cannabis industry, finding a few that have a chance at seeing profits can be a difficult task. But, if you know where to find a pot stock with potential, reaching profitability in your own port...
If you think oil and gas stocks have had a rough go of things in recent weeks, take a gander at marijuana stocks since March 31, 2019. Over the past year and change, most cannabis stocks have lost at least half of their value , with the losses being especially noticeable for Canadian pot stocks...
There is no doubt that it is a difficult time to be a marijuana stock investor . But, with good times, there will always be the inevitable downturns. After a few weeks of massive declines across the marijuana market, the last week of March proved to be quite positive for the cannabis industr...
BARRIE, Ontario, April 01, 2020 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivat...
MediPharm Labs Corporation (MEDIF) Q4 2019 Earnings Conference Call March 30, 2019 08:30 A.M. ET Company Participants Laura Lepore - VP, IR & Communications Pat McCutcheon - CEO and Chairman Bobby Kwon - CFO Keith Strachan - President Conference Call Participants Unid...
The following slide deck was published by Medipharm Labs Corporation in conjunction with their 2019 Q4 earnings Read more ...
MediPharm Labs ( OTCQX:MEDIF ): Q4 pre-tax loss of $2.4M More news on: Medipharm Labs Corporation, Earnings news and commentary, , Read more ...
• 2019 Revenue $129 Million, Adjusted EBITDA 1 $25 Million • Q4 2019 Revenue $32 Million, Adjusted EBITDA 1 $3 Million • Year-end Cash and Equivalents of $39 million BARRIE, Ontario, March 30, 2020 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: ...
The stock market may be the greatest long-term wealth creator, but it's not without its fair share of corrections and bear markets. The current bear market we're in just happens to be the steepest in recorded history , with the benchmark S&P 500 losing 34% of its value in a span of less t...
News, Short Squeeze, Breakout and More Instantly...
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders Canada NewsWire TORONTO , June 26, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical comp...
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols Canada NewsWire MediPharm has licenced global manufacturing, distribution, and sales rights of the novel advanced medical cannabis technology from Remidose Aerosols. Product...